Cypris Medical Inc announces the commercial release of its Xact handheld surgical suturing device designed to be used in minimally invasive face and neck lift suturing.
The Xact device is engineered to approximate and pass suture through soft tissue. It extends a surgeon’s hands, allowing them to place sutures precisely with less tissue disruption. This could help make procedures that use Xact less invasive, which could speed recovery time, according to the Chicago-based company in a media release.
“The first application of our Xact technology is designed to provide surgical outcomes of gravitational descent in the face and neck via a minimally invasive procedure,” says Dan Holton, its chief executive officer.
“It’s a favorable solution for the millions of patients who need more than neurotoxins and fillers, but don’t want to undergo a full face or neck lift,” he continues.
The Xact suturing device received FDA clearance in April 2017. The commercial launch follows an evaluation period in which patients demonstrated lasting results over 2 years.
“Minimally invasive options are becoming the standard in surgical procedures throughout medicine. It’s time for plastic surgery to advance, and the Xact device is well equipped to pioneer that shift,” states Dr Louis Bucky, a board-certified plastic surgeon, who serves on the Cypris Medical Advisory Board.
“This innovation can replace previous technologies, such as thread lifts, which have proven ineffective due to imprecise anatomic targets, limited longevity and high complication rates including thread extrusion,” Dr Christopher Godek, a board-certified plastic surgeon and lead clinical investigator for Xact, comments in the release.
“The Xact device effectively extends a surgeon’s hands into hard-to-reach areas. Utilizing small, two-centimeter-long incisions hidden within the hairline, surgeons can accurately and precisely lift, reposition and suture tissue,” Godek adds.
[Source(s): Cypris Medical Inc, Business Wire]
